Jonathan Salkin

Jonathan Salkin has a diverse and extensive work experience. Jonathan is currently serving as the Chief Executive Officer of Antylia Scientific since December 2021. Before that, they held the positions of President from November 2019 to December 2021 and Chief Operating Officer from November 2015 to November 2019 at the same company. Prior to their role at Antylia Scientific, Jonathan worked as the EVP, Corporate Development & Strategy at Devicor Medical Products from March 2009 to March 2015. Jonathan also served as the Managing Director, Head of Healthcare at The Royal Bank of Scotland plc from 2007 to 2009. Before that, they held the position of Vice President, Corporate Development at Cardinal Health from 2004 to 2007. Jonathan's career began at Wasserstein Perella & Co. in 2001, where they worked as the Director of Healthcare Mergers & Acquisitions until 2004. Jonathan started their career in 1997 as an Associate at BT Wolfensohn/BT Alex Brown.

Jonathan Salkin attended Case Western Reserve University from 1988 to 1992. Jonathan later pursued an MBA in Finance and Management Policy at the Weatherhead School of Management at Case Western Reserve University from 1991 to 1992. Salkin also attended the Case Western Reserve University School of Law from 1992 to 1995, but no degree or field of study was specified.